# Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT Prevention

> **NCT07243080** · PHASE4 · RECRUITING · sponsor: **Mayo Hospital Lahore** · enrollment: 212 (estimated)

## Conditions studied

- Deep Venous Thromboses
- Laparotomy Patients

## Interventions

- **DRUG:** rivaroxaban (10mg)
- **DRUG:** Enoxaparin 40 mg SC

## Key facts

- **NCT ID:** NCT07243080
- **Lead sponsor:** Mayo Hospital Lahore
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-10
- **Primary completion:** 2025-11-10
- **Final completion:** 2025-11-15
- **Target enrollment:** 212 (ESTIMATED)
- **Last updated:** 2025-11-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07243080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07243080, "Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT Prevention". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07243080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*